Expression of breast cancer anti-estrogen resistance 1 in relation to vascular endothelial growth factor, p53, and prognosis in esophageal squamous cell cancer

Diseases of the Esophagus

Volumn 26, Issue 5, 2013, Pages 528-537

  Huang, W ^a   Deng, B ^a   Wang, R W ^a   Tan, Q Y ^a   Jiang, Y G ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

BCAR1; ESCC; Ki 67; P53; VEGF

Indexed keywords

CRK ASSOCIATED SUBSTRATE PROTEIN; KI 67 ANTIGEN; NEDAPLATIN; PACLITAXEL; PROTEIN P53; VASCULOTROPIN;

ADULT; ARTICLE; CANCER PROGNOSIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL TIME; TISSUE MICROARRAY; TUMOR DIFFERENTIATION; WESTERN BLOTTING;

BCAR1; ESCC; KI-67; P53; VEGF;

CARCINOMA, SQUAMOUS CELL; CRK-ASSOCIATED SUBSTRATE PROTEIN; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; HUMANS; IMMUNOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; MALE; MIDDLE AGED; MITOTIC INDEX; PROGNOSIS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84880328211     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2012.01376.x     Document Type: Article

References (38)

1. Bavi P P, Bu R, Uddin S, Al-Kuraya K S. MMP7 Polymorphisms - a new tool in molecular pathology to understand esophageal cancer. Saudi J Gastroenterol 2011; 17: 299-300.
2. Lin D C, Du X L, Wang M R. Protein alterations in ESCC and clinical implications: a review. Dis Esophagus 2009; 22: 9-20.
3. Law S, Kwong D L, Kwok K F etal. Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy. Ann Surg 2003; 238: 339-47; discussion 347-8.
4. Donato D M, Ryzhova L M, Meenderink L M, Kaverina I, Hanks S K. Dynamics and mechanism of p130Cas localization to focal adhesions. J Biol Chem 2010; 285: 20769-79.
5. Defilippi P, Di Stefano P, Cabodi S. p130Cas: a versatile scaffold in signaling networks. Trends Cell Biol 2006; 16: 257-63.
6. Reynolds A B, Roesel D J, Kanner S B etal. Transformation-specific tyrosine phosphorylation of a novel cellular protein in chicken cells expressing oncogenic variants of the avian cellular src gene. Mol Cell Biol 1989; 9: 629-38.
7. Kanner S B, Reynolds A B, Parsons J T. Tyrosine phosphorylation of a 120-kilodalton pp60src substrate upon epidermal growth factor and platelet-derived growth factor receptor stimulation and in polyomavirus middle-T-antigen-transformed cells. Mol Cell Biol 1991; 11 713-20.
8. Brabek J, Constancio S S, Siesser P F, Shin N Y, Pozzi A, Hanks S K. Crk-associated substrate tyrosine phosphorylation sites are critical for invasion and metastasis of SRC-transformed cells. Mol Cancer Res 2005; 3: 307-15.
9. Tikhmyanova N, Little J L, Golemis E A. CAS proteins in normal and pathological cell growth control. Cell Mol Life Sci 2010; 67: 1025-48.
10. Dorssers L C, Grebenchtchikov N, Brinkman A etal. The prognostic value of BCAR1 in patients with primary breast cancer. Clin Cancer Res 2004; 10: 6194-202.
11. Fromont G, Vallancien G, Validire P, Levillain P, Cussenot O. BCAR1 expression in prostate cancer: association with 16q23 LOH status, tumor progression and EGFR/KAI1 staining. Prostate 2007; 67: 268-73.
12. Nick A M, Stone R L, Armaiz-Pena G etal. Silencing of p130Cas in ovarian carcinoma: a novel mechanism for tumor cell death. J Natl Cancer Inst 2011; 103: 1596-612.
13. Abdullah S E, Perez-Soler R. Mechanisms of resistance to vascular endothelial growth factor blockade. Cancer 2011; (in press).
14. Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L. Signal transduction by vascular endothelial growth factor receptors. Biochem J 2011; 437 169-83.
15. Kleespies A, Guba M, Jauch K W, Bruns C J. Vascular endothelial growth factor in esophageal cancer. J Surg Oncol 2004; 87: 95-104.
16. Takala H, Saarnio J, Wiik H, Ohtonen P, Soini Y. HIF-1alpha and VEGF are associated with disease progression in esophageal carcinoma. J Surg Res 2011; 167: 41-8.
17. Luo K J, Hu Y, Wen J, Fu J H. CyclinD1, p53, E-cadherin, and VEGF discordant expression in paired regional metastatic lymph nodes of esophageal squamous cell carcinoma: a tissue array analysis. J Surg Oncol 2011; 104: 236-43.
18. Suzuki K, Matsubara H. Recent advances in p53 research and cancer treatment. J Biomed Biotechnol 2011; 2011: (in press). Article ID 978312.
19. Uchida S, Shimada Y, Watanabe G etal. In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis. Br J Cancer 1998; 77: 1704-9.
20. Edge S B, Compton C C. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17 1471-4.
21. Deng B, Huang W, Tan Q Y etal. Breast cancer anti-estrogen resistance protein 1 (BCAR1/p130cas) in pulmonary disease tissue and serum. Mol Diagn Ther 2011; 15: 31-40.
22. Zhao M, Vuori K. The docking protein p130Cas regulates cell sensitivity to proteasome inhibition. BMC Biol 2011; 9: 73.
23. Sakai R, Iwamatsu A, Hirano N etal. A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. EMBO J 1994; 13: 3748-56.
24. Honda H, Oda H, Nakamoto T etal. Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas. Nat Genet 1998; 19: 361-5.
25. Wendt M K, Smith J A, Schiemann W P. p130Cas is required for mammary tumor growth and transforming growth factor-beta-mediated metastasis through regulation of Smad2/3 activity. J Biol Chem 2009; 284: 34145-56.
26. Cabodi S, Tinnirello A, Di Stefano P etal. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cancer Res 2006; 66: 4672-80.
27. Evans I M, Yamaji M, Britton G etal. Neuropilin-1 signaling through p130Cas tyrosine phosphorylation is essential for growth factor-dependent migration of glioma and endothelial cells. Mol Cell Biol 2011; 31: 1174-85.
28. Kang Y S, Kim W, Huh Y H, Bae J, Kim J S, Song W K. P130Cas attenuates epidermal growth factor (EGF) receptor internalization by modulating EGF-triggered dynamin phosphorylation. PLoS ONE 2011; 6: e20125.
29. Pellet-Many C, Frankel P, Evans I M, Herzog B, Junemann-Ramirez M, Zachary I C. Neuropilin-1 mediates PDGF stimulation of vascular smooth muscle cell migration and signalling via p130Cas. Biochem J 2011; 435: 609-18.
30. Frankel P, Pellet-Many C, Lehtolainen P etal. Chondroitin sulphate-modified neuropilin 1 is expressed in human tumour cells and modulates 3D invasion in the U87MG human glioblastoma cell line through a p130Cas-mediated pathway. EMBO Rep 2008; 9: 983-9.
31. Cho S Y, Klemke R L. Extracellular-regulated kinase activation and CAS/Crk coupling regulate cell migration and suppress apoptosis during invasion of the extracellular matrix. J Cell Biol 2000; 149: 223-36.
32. Wei L, Yang Y, Zhang X, Yu Q. Anchorage-independent phosphorylation of p130(Cas) protects lung adenocarcinoma cells from anoikis. J Cell Biochem 2002; 87: 439-49.
33. Lee D S, Kim S H, Suh Y J, Kim S, Kim H K, Shim B Y. Clinical implication of p53 overexpression in breast cancer patients younger than 50 years with a triple-negative subtype who undergo a modified radical mastectomy. Jpn J Clin Oncol 2011; 41: 854-66.
34. Coggi G, Bosari S, Roncalli M etal. p53 protein accumulation and p53 gene mutation in esophageal carcinoma. Cancer 1997; 79: 425-32.
35. Vogelstein B, Kinzler K W. p53 function and dysfunction. Cell 1992; 70: 523-6.
36. Kieser A, Weich H A, Brandner G, Marme D, Kolch W. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 1994; 9: 963-9.
37. Mukhopadhyay D, Tsiokas L, Sukhatme V P. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res 1995; 55: 6161-5.
38. Kim W, Seok Kang Y, Soo Kim J etal. The integrin-coupled signaling adaptor p130Cas suppresses Smad3 function in transforming growth factor-beta signaling. Mol Biol Cell 2008; 19: 2135-46.